PRODIGY PHARMA Trademark

Trademark Overview


On Wednesday, August 28, 2024, a trademark application was filed for PRODIGY PHARMA with the United States Patent and Trademark Office. The USPTO has given the PRODIGY PHARMA trademark a serial number of 98720939. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, January 26, 2026. This trademark is owned by Prodigy Biopharma LLC. The PRODIGY PHARMA trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Marketing services; providing advertising, marketing, and promotional services for the pharmaceutical and medical industry; marketing of telemedicine pharmaceutical preparations to be distributed via compounding pharmacies

Pharmaceutical compounding services not featuring substances containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis; production of cannabinoid-based pharmaceutical ingredients

Development of pharmaceutical preparations and medicines not containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis
prodigy pharma

General Information


Serial Number98720939
Word MarkPRODIGY PHARMA
Filing DateWednesday, August 28, 2024
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, January 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMarketing services; providing advertising, marketing, and promotional services for the pharmaceutical and medical industry; marketing of telemedicine pharmaceutical preparations to be distributed via compounding pharmacies
NOT AVAILABLEPHARMA
Goods and ServicesPharmaceutical compounding services not featuring substances containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis; production of cannabinoid-based pharmaceutical ingredients
Goods and ServicesDevelopment of pharmaceutical preparations and medicines not containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProdigy Biopharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33137

Trademark Events


Event DateEvent Description
Wednesday, August 28, 2024NEW APPLICATION ENTERED
Friday, January 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 4, 2025ASSIGNED TO EXAMINER
Tuesday, March 25, 2025ASSIGNED TO EXAMINER
Tuesday, March 25, 2025ASSIGNED TO EXAMINER
Wednesday, April 2, 2025NON-FINAL ACTION WRITTEN
Wednesday, April 2, 2025NON-FINAL ACTION E-MAILED
Wednesday, April 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 30, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 25, 2025SUSPENSION LETTER WRITTEN
Friday, July 25, 2025LETTER OF SUSPENSION E-MAILED
Friday, July 25, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 26, 2026REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED